Keyword Connections

osteoclasts

Journals

4

1 International journal of molecular sciences

2 Medicine

3 Journal of molecular histology

4 Journal of pineal research

Research Groups

0

No Research Group Connected

Bibliographies

14

1 Melatonin is a potential drug for the prevention of bone loss during space flight.

2 Periodontal ligament-associated protein-1 gets involved in the development of osseous eruption canal.

3 Association between the aspartic acid D-repeat polymorphisms and osteoarthritis susceptibility: An updated systematic review and meta-analyses.

4 Regulation of Osteoclast Differentiation at Multiple Stages by Protein Kinase D Family Kinases.

5 phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations

6 a matrine derivative m54 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by targeting ribosomal protein s5

7 modulation of osteoclast interactions with orthopaedic biomaterials

8 the influence of different nonsteroidal anti-inflammatory drugs on alveolar bone in rats: an experimental study

9 Crosstalk between Fas and S1P<inf>1</inf> signaling via NF-kB in osteoclasts controls bone destruction in the TMJ due to rheumatoid arthritis

10 Author Correction: Sensory innervation in porous endplates by Netrin-1 from osteoclasts mediates PGE2-induced spinal hypersensitivity in mice (Nature Communications, (2019), 10, 1, (5643), 10.1038/s41467-019-13476-9)

11 pantoprazole decreases cell viability and function of human osteoclasts in vitro

12 osteoclasts and cd8 t cells form a negative feedback loop that contributes to homeostasis of both the skeletal and immune systems

13 the f-actin modulator swap-70 controls podosome patterning in osteoclasts

14 Corrigendum to “MicroRNA-25-3p regulates osteoclasts through nuclear factor I X” [Biochem. Biophys. Res. Commun. 522(1) (2020) 74–80, (Biochemical and Biophysical Research Communications (2020) 522(1) (74-80) (S0006291X1932162X), (10.1016/j.bbrc.2019.11.043))